S Nylander1, K Johansson, J J J Van Giezen
1Department of Molecular Pharmacology, Preclinical R&D, AstraZeneca R&D, Mölndal, Sweden. sven.nylander@astrazeneca.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Two new platelet function assays, fibrinogen receptor activation and residual platelet counting, show promise for screening. They correlate well with established methods and offer reliable alternatives for drug evaluation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: